These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6230055)

  • 41. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early phase II study of YM 881 (zinostatin stimalamer) by intravenous injection. Research group for intravenous YM 881].
    Saito T; Nakao I; Wakui A; Niitani H; Kurihara M; Konno T; Tsukagoshi S; Maeda H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1319-23. PubMed ID: 1829883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
    Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [TAC-278. A new 5-FU derivative, by the oral route for its efficacy and safety in 36 patients with advanced cancers].
    Watanabe K; Satoh H; Ohki S; Furue H; Komita T; Iketa T; Ikenaga M; Arimori S; Nagao T; Yamamoto S
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):675-80. PubMed ID: 7184420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study.
    Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E
    J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [TUT-7 phase I clinical study. TUT-7 Study Group].
    Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Nakao I; Ota K; Hattori T; Sugimachi K
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1125-33. PubMed ID: 9239166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Phase I study of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakao I; Saito T; Kimura K; Wakui A; Yokoyama M; Kanamaru R; Furue H; Komita T; Ohta K; Murakami M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2037-43. PubMed ID: 2932058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Co-operative clinical evaluation of 5'-DFUR tablets for breast cancer at 31 institutions].
    Morimoto K; Taguchi T; Ohta J; Miura S; Ueda N; Yayoi K; Inaji H
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1041-8. PubMed ID: 1385688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group].
    Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3345-50. PubMed ID: 2961307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice].
    Fujita F; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of oral administration of 5'-deoxy-5-fluorouridine (5'-DFUR) for solid tumors.
    Shimizu E; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Fujita J; Nomori H; Hoshi A
    Jpn J Clin Oncol; 1984 Dec; 14(4):679-83. PubMed ID: 6240546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of CDDP administration into the body cavity].
    Kikuchi K; Fujisaki M; Tamura T; Takahashi R; Kurihara E; Takada Y; Suito T; Uematsu Y
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3253-8. PubMed ID: 3688890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.
    Sullivan RD; Miller E
    Cancer Res; 1965 Aug; 25(7):1025-33. PubMed ID: 4284747
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
    Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
    Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
    [No Abstract]   [Full Text] [Related]  

  • 59. [Survival and changes of clinical laboratory data in phase II study with 5'-DFUR].
    Taguchi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1019-29. PubMed ID: 8687216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial.
    Carpenter JT; Raney M; Logan T
    Cancer Treat Rep; 1986 May; 70(5):679-80. PubMed ID: 3708619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.